ARBs (Angiotensin Blockers)
9 drugs in this class, prescribed by 346,031 Medicare Part D providers.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$1.74B
Total Cost
22,273,334
Claims
9
Drugs
$78
Avg Cost/Claim
Key Insights
- Most expensive per prescription: Entresto at $1,066/claim
- Most prescribed: Losartan Potassium with 14,466,748 claims
- This class represents 0.6% of total Medicare Part D spending
All ARBs (Angiotensin Blockers) Drugs
| Drug | Cost | Claims |
|---|---|---|
| Sacubitril/Valsartan | $1.30B | 1,220,812 |
| Losartan Potassium | $213.4M | 14,466,748 |
| Valsartan | $56.4M | 1,481,937 |
| Losartan/Hydrochlorothiazide | $46.3M | 2,039,676 |
| Olmesartan Medoxomil | $33.8M | 1,102,412 |
| Irbesartan | $30.1M | 869,928 |
| Valsartan/Hydrochlorothiazide | $27.5M | 510,583 |
| Telmisartan | $16.4M | 334,601 |
| Olmesartan/Hydrochlorothiazide | $13.9M | 246,637 |